WHITE BIOTECHNOLOGY MARKET ANALYSIS
Global white biotechnology market is estimated to be valued at USD 304.10 Bn in 2024 and is expected to reach USD 601.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031.
Discover market dynamics shaping the industry: Request sample copy
The market is expected to witness significant growth during the forecast period due to factors like rising focus on development of renewable fuels and chemicals, increasing demand for bio-based products, and growing need for sustainable production processes. Government initiatives promoting sustainable development and use of eco-friendly technologies can drive the market growth. Adoption of innovative and energy-efficient bioprocesses can boost demand for white biotechnology. Continued investments in research and development of new products can offer opportunities for manufacturers in the near future. However, high capital requirement for setting up production facilities and lack of unified regulatory norms can hamper the market growth.
Growing applications of biotechnology in food and agriculture industries
Rising white biotechnology application in food and agriculture industries can drive the market growth. Biotechnology techniques are being utilized to develop high yield crop varieties, improve animal health and productivity, produce biopesticides and biofertilizers, and discover new sources of food. Rising global population puts immense pressure on the agriculture sector to increase crop and livestock yields in a sustainable manner. Traditional agricultural practices alone may not be sufficient to meet the escalating global demand for food. Thus, white biotechnology interventions can play a crucial role by boosting agricultural outputs. Several aggrotech companies leverages the power of industrial bioprocesses, enzymes, microbial solutions and modern breeding technologies to engineer new plant varieties and animal breeds that are resistant to diseases and capable of growing in a wider range of climatic conditions with lesser dependence on chemical inputs. For instance, gene editing tools like CRISPR are being deployed to develop crops that are higher yielding as well as tolerant to drought, flood and salinity. Biotechnological advancements are also enhancing the nutritional quality and shelf life of agricultural produce to reduce post-harvest losses. Biobased pesticides and biofertilizers developed using beneficial microbes are gaining popularity among farmers as sustainable alternatives to chemical pesticides for promoting plant growth and preventing infestations.
Get actionable strategies to beat competition: Request sample copy
Growing demand for renewable resources and environment friendly products
Increasing worldwide focus on sustainability and reducing carbon footprint has boosted demand for renewable and environment-friendly products across industries. More companies and consumers seek options that minimize negative impact on the environment. This shift towards greener alternatives can drive the white biotechnology market growth globally. White biotechnology utilizes micro-organisms and enzymes for industrial applications like manufacturing renewable chemicals, developing alternative fuels, reducing waste, and more. By leveraging nature's solutions, white biotech enable a circular bio-economy. For food and beverage companies, it allows developing sustainable and plant-based packaging, additives, and ingredients. The chemical industry is investing in white biotech to produce industrial enzymes for more efficient and less polluting manufacturing processes. Biofuels developed through white biotech methods offer cleaner and renewable alternatives to fossil fuels for the transportation sector. In 2022, according to the report published by International Renewable Energy Agency, biofuel production had increased by 43% between 2020 and 2023 due to rising demand for sustainable fuels.
Key Takeaways from Analyst:
Global white biotechnology market growth is driven by rising demand for green and sustainable products across industries such as food and beverage, chemicals, and biofuels. Increasing consumer inclination towards eco-friendly, natural and organic products is expected to boost demand for bio-based goods manufactured using white biotech techniques. Stringent regulations curbing the use of chemicals boosts adoption of cleaner production technologies. The bio-based chemicals and bioplastics segment in particular looks promising with global brands actively pursuing bio-based alternatives to conventional plastics.
Requirement of high infrastructure investment could hinder the large-scale commercialization of certain white biotech processes, especially in developing regions with limited capital. Uncertainty regarding the long-term viability of new bio-based technologies can also hamper the market growth. North America currently dominates the market due to supportive government policies. The market growth in Europe is driven by the need to achieve sustainability targets. Asia Pacific is likely to be the fastest-growing market, led by countries like China and India, where significant capacity additions are planned across sectors like biofuels, bioplastics, and food additives.
Market Challenges High initial capital investment requirements
High initial capital investment requirements can hamper the global white biotechnology market growth. Setting up facilities for white biotechnology processes that utilize living organisms and biological systems to produce industrial goods requires huge capital investments. Establishing bioreactors, microbial culture production units, downstream processing units and sterilization equipment demands large capital outlays running into millions of dollars. For instance, building a traditional chemical plant involves capital expenditure of around US$ 500 million whereas a comparable biotech plant requires over US$ 1 billion in investments. The high dependence on specialized and technologically advanced bioprocessing equipment increases costs significantly. Continuous research and development is needed to optimize and scale-up the biological production pathways, and this increases cost.
Market Opportunities: Potential for market expansion in emerging countries
Market expansion in emerging countries can offer growth opportunities. Many developing nations are undergoing rapid urbanization and economic growth, and this boosts demand for goods and services. This includes higher demand for sustainable and eco-friendly products produced through white biotechnology. Countries like India, China, Brazil and Indonesia have huge populations and growing middle class consumers, and this can boost consumption. According to the data from United Nations Department of Economic and Social Affairs, the middle class in Asia Pacific is expected to grow from 1.9 billion in 2020 to 3.8 billion by 2030. Large populations with rising disposable incomes in emerging nations can offer opportunities for market growth. Several emerging economies also recognize white biotechnology as an important industry for sustainable development goals. Governments of countries like India and Brazil have launched initiatives to boost research, innovation and commercialization in industrial biotechnology sector. For example, the Government of India's Biotechnology Industry Research Assistance Council (BIRAC) had partnered with Bill & Melinda Gates Foundation to build enterprises that apply industrial biotechnology solutions to challenges faced by small and marginal farmers. Such initiatives aim to develop affordable and environmental-friendly applications for sectors like agriculture, white goods and renewable energy. These also incentivize local and global companies to set up manufacturing bases in these nations to cater to growing domestic and export demands.
Discover high revenue pocket segments and roadmap to it: Request sample copy
Insights, By Product Type: Biochemical Dominates Due to Wide Applications Across Industries
Among product type, biochemical segment is estimated to contribute the highest market share of 32.1% in 2024 due to the immense versatility of biochemicals and their ability to be applied across a wide range of industries. Biochemicals such as enzymes, organic acids, and amino acids all have critical functions in sectors like pharmaceuticals, food processing, cleaning products, and more. Within pharmaceuticals, biochemicals are essential ingredients in the production of medicines. Enzymes aid in the synthesis of drug compounds and help create advanced drug delivery mechanisms. Biochemicals are also core components of health and wellness products. Amino acidsare commonly added to nutritional supplements, skin care items, and dietary supplements due to their beneficial properties. The food industry relies heavily on biochemicals for processing, preserving, and enhancing foods. Organic acids and enzymes allow for more efficient production of baked goods, dairy products, and beverages. These facilitate processes like fermentation and improve shelf life. Biochemicals further aid food production through their usage as preservatives, acidulants, and flavorings. Beyond pharmaceuticals and food, biochemicals are pivotal to manufacturing of cleaning supplies and cosmetics. Enzymes act as active ingredients in detergents that break down stains and odors. Amino acids are frequently incorporated into personal care items due to their moisturizing and rejuvenating qualities.
By Application: Bioenergy Dominates Due to Sustainability Initiatives
Among application, bioenergy segment is estimated to contribute the highest market share of 30.10 % in 2024 due to the increased emphasis on developing renewable and sustainable energy sources globally. While fossil fuels remain dominant, mounting environmental concerns are driving escalated investment and research into biofuels. Biofuels produced through white biotechnological means offer a cleaner alternative to traditional gasoline and diesel. Ethanol extracted from biomass and biodiesel manufactured from vegetable oils generate less toxic emissions. These are also partially comprised of carbon already present in the atmosphere, minimizing additional carbon dioxide release during combustion. Some advanced biofuels even manage net-negative emissions over their lifecycles. To reduce dependence on imported oil and lower carbon footprints, many countries have instituted biofuel blending mandates and support programs. Substantial subsidies and tax incentives are also provided to biofuel producers and consumers. These policies stimulate strong domestic biofuel industries and greater use of low-carbon alternatives in vehicles. Automakers, airlines, and other transport entities are equally driving the shift to bioenergy applications.
To learn more about this report, Request sample copy
North America has established itself as the dominant region in the global white biotechnology market with an estimated market share of 38.2 % in 2024. The U.S. is home to several large biotech firms that are leaders in industrial biotech applications. These companies have significantly invested in R&D over the years to develop new and innovative technologies. The region also has a very conducive business environment and supportive government policies that promote innovation. Research institutes in the U.S. and Canada work closely with industry to foster collaboration and commercially viable solutions.
Strong intellectual property protection further encourages businesses to freely develop new-to-world ideas and processes. North America also has a highly skilled workforce and top-ranked universities that nurture talent in emerging fields like synthetic biology and industrial biomanufacturing. This extensive research ecosystem and holistic industry support has enabled the region to consistently introduce groundbreaking products across multiple sectors. The availability of risk capital from both private and public sources also provides a big advantage for companies to scale up from early-stage innovations.
The Asia Pacific region has emerged as the fastest growing market. Countries like China, India, Japan and South Korea are aggressively investing in homegrown R&D capabilities as well as acquiring foreign technology to catch up with industry leaders. China has designated white biotech as a key priority area under its high-tech industrial development plans. Several special economic zones offer tax incentives for businesses setting up manufacturing bases and research facilities. The massive population size also provides a huge local market for green chemicals, biomaterials, renewable energy and other sustainable solutions produced using industrial biotech routes.
White Biotechnology Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 304.10 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 10.2% | 2031 Value Projection: | US$ 601.10 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Medtronic, Novozymes, BASF SE, DuPont, Cargill, Inc., Royal DSM N.V., Archer Daniels Midland Company, BioAmber Inc., Lesaffre, Corbion N.V., Evonik Industries AG, Genomatica, Inc., Ginkgo Bioworks, Amyris Inc., TerraVia Holdings, Inc, Metabolic Explorer SA, Codexis Inc., Danisco A/S, Biocatalysts Ltd. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
*Definition: Global white biotechnology market involves the application of industrial processes and organisms for sustainable and environmentally-friendly manufacturing. It utilizes enzymes, microorganisms and processes to produce industrial chemicals, materials and energy through fermentation. Some key areas of white biotechnology include biofuels and bioplastics production, industrial bioprocesses and agricultural applications. White biotechnology is gaining traction due to the growing demand for sustainable and renewable production methods across industries like food processing, paper and pulp and bioenergy.
Share
About Author
Abhijeet Kale is a results-driven management consultant with five years of specialized experience in the biotech and clinical diagnostics sectors. With a strong background in scientific research and business strategy, Abhijeet helps organizations identify potential revenue pockets, and in turn helping clients with market entry strategies. He assists clients in developing robust strategies for navigating FDA and EMA requirements.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Credibility and Certifications
860519526
9001:2015
27001:2022
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowSelect a License Type
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India :